Table of Contents
ISRN Oncology
Volume 2011 (2011), Article ID 168712, 10 pages
http://dx.doi.org/10.5402/2011/168712
Research Article

High Expression of Complement Component 5 (C5) at Tumor Site Associates with Superior Survival in Ewing's Sarcoma Family of Tumour Patients

1Department of Pathology, Haartman Institute and HUSLAB, University of Helsinki and Helsinki University Central Hospital, 00014, Helsinki, Finland
2Department of Information and Computer Science, Aalto University School of Science, 02015, Espoo, Finland
3Laboratorio di Ricerca Oncologica, Istituti Ortopedici Rizzoli, 40136, Bologna, Italy
4Hematology Research Unit, Helsinki University Central Hospital, P.O. Box 700, 00290, Helsinki, Finland

Received 1 July 2011; Accepted 24 July 2011

Academic Editors: B. Comin-Anduix and K. Sonoda

Copyright © 2011 Suvi Savola et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Vakkila and M. T. Lotze, “Inflammation and necrosis promote tumour growth,” Nature Reviews Immunology, vol. 4, no. 8, pp. 641–648, 2004. View at Google Scholar · View at Scopus
  2. W. H. Wang, J. Q. Huang, G. F. Zheng, S. K. Lam, J. Karlberg, and B. C. Y. Wong, “Non-steroidal anti-inflammatory drug use and the risk of gastric cancer: a systematic review and meta-analysis,” Journal of the National Cancer Institute, vol. 95, no. 23, pp. 1784–1791, 2003. View at Google Scholar · View at Scopus
  3. A. Gonzalez-Perez, L. A. Garcia Rodriguez, and R. Lopez-Ridaura, “Effects of non-steroidal anti-inflammatory drugs on cancer sites other than the colon and rectum: a meta-analysis,” BMC Cancer, vol. 3, no. 28, 2003. View at Google Scholar
  4. E. S. Schernhammer, J. H. Kang, A. T. Chan et al., “A prospective study of aspirin use and the risk of pancreatic cancer in women,” Journal of the National Cancer Institute, vol. 96, no. 1, pp. 22–28, 2004. View at Google Scholar · View at Scopus
  5. D. S. Dickens, R. Kozielski, P. J. Leavey, C. Timmons, and T. P. Cripe, “Cyclooxygenase-2 expression does not correlate with outcome in osteosarcoma or rhabdomyosarcoma,” Journal of Pediatric Hematology/Oncology, vol. 25, no. 4, pp. 282–285, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Vakkila, R. Jaffe, M. Michelow, and M. T. Lotze, “Pediatric cancers are infiltrated predominantly by macrophages and contain a paucity of dendritic cells: a major nosologic difference with adult tumors,” Clinical Cancer Research, vol. 12, no. 7, pp. 2049–2054, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. P. Rosito, A. F. Mancini, R. Rondelli et al., “Italian cooperative study for the treatment of children and young adults with localized ewing sarcoma of bone: a preliminary report of 6 years of experience,” Cancer, vol. 86, no. 3, pp. 421–428, 1999. View at Publisher · View at Google Scholar · View at Scopus
  8. G. Bacci, A. Balladelli, C. Forni et al., “Adjuvant and neo-adjuvant chemotherapy for Ewing's sarcoma family tumors and osteosarcoma of the extremity: further outcome for patients event-free survivors 5 years from the beginning of treatment,” Annals of Oncology, vol. 18, no. 12, pp. 2037–2040, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Savola, A. Klami, A. Tripathi et al., “Combined use of expression and CGH arrays pinpoints novel candidate genes in Ewing sarcoma family of tumors,” BMC Cancer, vol. 9, article 17, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. T. Barrett, D. B. Troup, S. E. Wilhite et al., “NCBI GEO: mining tens of millions of expression profiles—database and tools update,” Nucleic Acids Research, vol. 35, no. 1, pp. D760–D765, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. A. I. Su, M. P. Cooke, K. A. Ching et al., “Large-scale analysis of the human and mouse transcriptomes,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 7, pp. 4465–4470, 2002. View at Publisher · View at Google Scholar · View at Scopus
  12. E. Birney, T. D. Andrews, P. Bevan et al., “An overview of Ensembl,” Genome Research, vol. 14, no. 5, pp. 925–928, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. R. A. Irizarry, B. Hobbs, F. Collin et al., “Exploration, normalization, and summaries of high density oligonucleotide array probe level data,” Biostatistics, vol. 4, no. 2, pp. 249–264, 2003. View at Google Scholar · View at Scopus
  14. J. D. Storey and R. Tibshirani, “Statistical significance for genomewide studies,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 16, pp. 9440–9445, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. L. M. Coussens and Z. Werb, “Inflammation and cancer,” Nature, vol. 420, no. 6917, pp. 860–867, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. T. Loning, J. Liebsch, and G. Delling, “Osteosarcomas and Ewing's sarcomas. Comparative immunocytochemical investigation of filamentous proteins and cell membrane determinants,” Virchows Archiv, vol. 407, no. 3, pp. 323–336, 1985. View at Google Scholar · View at Scopus
  17. A. Mantovani, S. Sozzani, M. Locati, P. Allavena, and A. Sica, “Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes,” Trends in Immunology, vol. 23, no. 11, pp. 549–555, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. C. E. Lewis and J. W. Pollard, “Distinct role of macrophages in different tumor microenvironments,” Cancer Research, vol. 66, no. 2, pp. 605–612, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. Y. S. Lau, I. E. Adamopoulos, A. Sabokbar, H. Giele, C. L. M. H. Gibbons, and N. A. Athanasou, “Cellular and humoral mechanisms of osteoclast formation in Ewing's sarcoma,” British Journal of Cancer, vol. 96, no. 11, pp. 1716–1722, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. A. O'Regan and J. S. Berman, “Osteopontin: a key cytokine in cell-mediated and granulomatous inflammation,” International Journal of Experimental Pathology, vol. 81, no. 6, pp. 373–390, 2000. View at Publisher · View at Google Scholar · View at Scopus
  21. L. F. Brown, A. Papadopoulos-Sergiou, B. Berse et al., “Osteopontin expression and distribution in human carcinomas,” American Journal of Pathology, vol. 145, no. 3, pp. 610–623, 1994. View at Google Scholar · View at Scopus
  22. D. J. J. Waugh and C. Wilson, “The interleukin-8 pathway in cancer,” Clinical Cancer Research, vol. 14, no. 21, pp. 6735–6741, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Staerk, A. Kallin, J. B. Demoulin, W. Vainchenker, and S. N. Constantinescu, “JAK1 and Tyk2 activation by the homologous polycythemia vera JAK2 V617F mutation: cross-talk with IGF1 receptor,” Journal of Biological Chemistry, vol. 280, no. 51, pp. 41893–41899, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. H. Xiong, Z. G. Zhang, X. Q. Tian et al., “Inhibition of JAK1, 2/STAT3 signaling induces apoptosis, cell cycle arrest, and reduces tumor cell invasion in colorectal cancer cells,” Neoplasia, vol. 10, no. 3, pp. 287–297, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. S. R. Marder, D. E. Chenoweth, I. M. Goldstein, and H. D. Perez, “Chemotactic responses of human peripheral blood monocytes to the complement-derived peptides C5a and C5a des Arg,” Journal of Immunology, vol. 134, no. 5, pp. 3325–3331, 1985. View at Google Scholar · View at Scopus
  26. R. F. Guo and P. A. Ward, “Role of C5a in inflammatory responses,” Annual Review of Immunology, vol. 2, pp. 821–852, 2005. View at Google Scholar
  27. M. G. Strainic, J. Liu, D. Huang et al., “Locally produced complement fragments C5a and C3a provide both costimulatory and survival signals to naive CD4+ T cells,” Immunity, vol. 28, no. 3, pp. 425–435, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. P. N. Lalli, M. G. Strainic, M. Yang, F. Lin, M. E. Medof, and P. S. Heeger, “Locally produced C5a binds to T cell expressed C5aR to enhance effector T-cell expansion by limiting antigen-induced apoptosis,” Blood, vol. 112, no. 5, pp. 1759–1766, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. M. M. Markiewski, R. A. DeAngelis, F. Benencia et al., “Modulation of the antitumor immune response by complement,” Nature Immunology, vol. 9, no. 11, pp. 1225–1235, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. I. U. Schraufstatter, R. G. DiScipio, M. Zhao, and S. K. Khaldoyanidi, “C3a and C5a are chemotactic factors for human mesenchymal stem cells, which cause prolonged ERK1/2 phosphorylation,” Journal of Immunology, vol. 182, no. 6, pp. 3827–3836, 2009. View at Publisher · View at Google Scholar · View at Scopus